Quantcast

Industry news that matters to you.  Learn more

Van Andel Research Institute to Utilize Aushon BioSystems’ Microarray Technology

Reading time: 2 minutes

Aushon BioSystems, Inc., a leading provider of advanced microarray instrumentation and laboratory services for biomarker discovery, development and analysis, announced today that the Van Andel Research Institute (VARI), part of the Van Andel Institute, will utilize the Aushon 2470 Arrayer technology in its Laboratory of Cancer Immunodiagnostics to advance research efforts focusing on developing novel protein analysis methods to identify and study protein abnormalities in the blood of cancer patients. The goal of the research is to develop blood tests for the early detection or more accurate diagnosis of cancer.

“Our lab produces a wide variety of microarrays, including antibody, protein, glycan, small molecule, and RNAi,” says Brian Haab, Senior Scientific Researcher at Van Andel’s Laboratory of Cancer Immunodiagnostics. “With such a diverse mix, we need to ensure that we have good consistency between arrays, as well as reliability and speed in the printing platform. The 2470 has those critical capabilities – reliability, consistency, speed – plus the ability to produce many arrays with many different elements in a reasonable amount of time.”

The Aushon 2470 Arrayer has been installed in leading institutions throughout North America, Europe and Asia to provide rapid, accurate, high-density microarray printing for both genomic and proteomic applications. It is able to print virtually any sample – including cell lysates and blood – onto substrates with unique shapes and chemistries, as well as the most delicate of substrates such as nitrocellulose and silicon chips. Engineered with walk-away automation, the unique solid pin architecture and proprietary pin design make the 2470 the most flexible and reliable microarray printing platform available.

Source: Aushon BioSystems